A Retrospective Study on Hospitalized Patients With Community-acquired Pneumonia in China (CAP-China) (RSCAP-China)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02489578|
Recruitment Status : Unknown
Verified October 2015 by Bin Cao, Capital Medical University.
Recruitment status was: Recruiting
First Posted : July 3, 2015
Last Update Posted : October 16, 2015
|Condition or disease||Intervention/treatment|
|Community Acquired Pneumonia||Other: other|
In China, the data about current management of patients hospitalized with CAP in the real-life setting is not available,type of pneumonia, selection of initial antibiotic, time to clinical stability, antibiotic choice anf modification,clinical outcomes and costs remain unclear.
In this study, we will collect comprehensive information on CAP and HCAP management patterns to evaluate the disease burden of hospitalized patients with CAP and HCAP in real life of China .to analyze microbiological characteristics,clinical manifestations,antibiotic regimens ,adherences to guidelines and effect on outcome in different groups of patients with CAP (> and = 65 years, different comorbidities ,risk factors) ,to investigate microbiological characteristics,clinical manifestations,antibiotic regimens ,adherences to guidelines and effect on outcome in different groups of disease severity with CAP ,to provide the difference on microbiological characteristics,clinical manifestations,antibiotic regimens ,and outcome between patients with CAP and HCAP ,to understand the current situation of antibiotic regimen ,to evaluate influence of different antibiotic regimens on prognosis.
|Study Type :||Observational|
|Estimated Enrollment :||3000 participants|
|Official Title:||Management in Real-life of Patients Hospitalized With Community-acquired Pneumonia in China|
|Study Start Date :||July 2015|
|Estimated Primary Completion Date :||December 2016|
|Estimated Study Completion Date :||December 2016|
- Other: other
retrospective cohort study
- treatment failure at 72h after initiation of antibiotics [ Time Frame: Time from the first dose use of antibiotics to 72 hours ]treatment failure was defined as a change of antibiotics due to worsening signs or symptoms associated with pneumonia
- in-hospital treatment failure due to multiple causes [ Time Frame: Time from date of admission to discharge up to 1 week ]1)death in hospital;2)change of antibiotics due to worsening signs or symptoms of infection, 3) recurrence, defined as signs or symptoms of infection after completion of therapy requiring re-initiation of antibiotics
- Duration of intravenous antimicrobial therapy [ Time Frame: 2 weeks ]Time from the first dose of intravenous antibiotics to date of stop of intravenous antibiotics ,participants will be followed for the duration of hospital stay
- Hospital length of stay [ Time Frame: 2 weeks ]Patients will be asked about hospitalization, date, Patients will be asked about hospitalization, date, participants will be asked about the time of admission and discharge
- in-hospital mortality [ Time Frame: 2 weeks ]Time from date of admission to date of discharge,participants will be followed for the duration of hospital stay
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02489578
|Contact: Bin Cao, MDfirstname.lastname@example.org|
|Contact: LI Gu, MDemail@example.com|
|Study Chair:||Bin Cao, MD||China-Japan Friendship Hospital|